Robert Eckert
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Amgen Outperforms Market Amid Dow Jones Rotation. Amgen has recently exceeded broader market returns, a trend highlighted in recent analyses of Dow Jones stocks making bullish moves during defensive market rotations. This performance contrasts with peers like Merck, where analysts are comparing dividend growth potential. While the stock shows relative strength, it remains within its 52-week range, with the average analyst target price set significantly above current levels.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Uber Settles Sexual Assault Lawsuit; Valuation Discount Highlighted. Uber’s recent filings show a settlement of a sexual‑assault lawsuit, which may ease concerns about its safety record. A Guggenheim note highlights a valuation discount relative to revenue and profit growth, while a separate analysis explains why the firm’s strategy was exited by a major investor. Comparisons with Coupang suggest Uber’s revenue growth is steadier than some peers. These developments provide context for the current trading range near the 52‑week low.
Transaction History
| LEVI | ▲ Buy | Grant | 381 | $0 | 8/5/2026 | View on chart |
| AMGN | ▲ Buy | Grant | 665 | $0 | 5/19/2026 | View on chart |
| LEVI | ▲ Buy | Grant | 355 | $0 | 5/6/2026 | View on chart |
| LEVI | ▲ Buy | Grant | 8,381 | $0 | 4/22/2026 | View on chart |
| LEVI | ▲ Buy | Grant | 316 | $0 | 2/25/2026 | View on chart |
| LEVI | ▲ Buy | Grant | 358 | $0 | 11/4/2025 | View on chart |
| LEVI | ▲ Buy | Grant | 346 | $0 | 8/8/2025 | View on chart |
| AMGN | ▲ Buy | Grant | 809 | $0 | 5/23/2025 | View on chart |
| LEVI | ▲ Buy | Grant | 370 | $0 | 5/9/2025 | View on chart |
| LEVI | ▲ Buy | Grant | 18,370 | $0 | 4/23/2025 | View on chart |
| LEVI | ▲ Buy | Grant | 220 | $0 | 2/28/2025 | View on chart |
| LEVI | ▲ Buy | Grant | 234 | $0 | 11/14/2024 | View on chart |
| LEVI | ▲ Buy | Grant | 205 | $0 | 8/20/2024 | View on chart |
| AMGN | ▲ Buy | Grant | 719 | $0 | 5/31/2024 | View on chart |
| LEVI | ▲ Buy | Grant | 165 | $0 | 5/23/2024 | View on chart |
| LEVI | ▲ Buy | Grant | 12,573 | $0 | 4/24/2024 | View on chart |
| LEVI | ▲ Buy | Grant | 114 | $0 | 2/23/2024 | View on chart |
| LEVI | ▲ Buy | Grant | 147 | $0 | 11/9/2023 | View on chart |
| LEVI | ▲ Buy | Grant | 148 | $0 | 8/17/2023 | View on chart |
| AMGN | ▲ Buy | Grant | 939 | $0 | 5/19/2023 | View on chart |
| LEVI | ▲ Buy | Grant | 270 | $0 | 5/18/2023 | View on chart |
| LEVI | ▲ Buy | Grant | 16,865 | $0 | 4/19/2023 | View on chart |
| LEVI | ▲ Buy | Grant | 401 | $0 | 2/23/2023 | View on chart |
| LEVI | ▲ Buy | Grant | 176 | $0 | 2/23/2023 | View on chart |
| LEVI | ▲ Buy | Grant | 652 | $0 | 11/21/2022 | View on chart |
| AMGN | ▼ Sell | Open Market | 6,600 | $1.6M | 8/18/2022 | View on chart |
| LEVI | ▲ Buy | Grant | 521 | $0 | 8/17/2022 | View on chart |
| AMGN | ▲ Buy | Option Exercise | 20,000 | $1.7M | 8/10/2022 | View on chart |
| AMGN | ▼ Sell | Tax Withholding | 6,791 | $1.7M | 8/10/2022 | View on chart |
| LEVI | ▲ Buy | Grant | 584 | $0 | 5/24/2022 | View on chart |
| AMGN | ▲ Buy | Grant | 855 | $0 | 5/17/2022 | View on chart |
| UBER | ▲ Buy | Option Exercise | 2,460 | $0 | 5/8/2022 | View on chart |
| LEVI | ▲ Buy | Grant | 12,852 | $0 | 4/20/2022 | View on chart |
| LEVI | ▲ Buy | Grant | 374 | $0 | 2/24/2022 | View on chart |
| UBER | ▲ Buy | Option Exercise | 4,772 | — | 12/31/2021 | View on chart |
| LEVI | ▲ Buy | Grant | 234 | $0 | 11/17/2021 | View on chart |
| LEVI | ▲ Buy | Grant | 240 | $0 | 8/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Levi Strauss Names New CFO, Signals Potential Strategic Shift
Levi Strauss & Co announced a new CFO, which could influence the company's strategy and financial outlook. The change comes as the company continues to navigate market conditions. Analysts are watching the appointment for potential shifts in financial management. The move may affect investor perception of the brand's future.
Levi Strauss Names New CFO, Signals Potential Strategic Shift. Levi Strauss & Co announced a new CFO, which could influence the company's strategy and financial outlook. The change comes as the company continues to navigate market conditions. Analysts are watching the appointment for potential shifts in financial management. The move may affect investor perception of the brand's future.